Lung infections by SARS-CoV-2 could lead to elevated blood sugar levels by adipose dysfunction in adiponectin and adiponectin/leptin ratios [124,125], making it difficult to control infections and metabolic diseases with sarcopenia or obesity [126]. The gene discussed is ADIPOQ; the disease is Other metabolic disease.